Stock Evaluator: Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd. CLBT

$11.05 -0.26 -2.30%
August 21, 2026 4:00:00 PM EST November 10, 2021 Volume: 3,812,450
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Information Technology Software

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Commentary & Analysis


Financial Summary

Share Statistics CLBT Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $2,771.2 $1,092.1 58%
Shares Out (Mil) 252.8 78.5 80%
Institutional Ownership 96.4% 80.9% 70%
Float (Mil) 125.2 53.1 65%
Beta na 1.01 na
Avg Daily Volume (000s) 8,033 793 95%
Price Change
(52-week)
(28.6%) 57.8% 24%
Growth CLBT Industry
Median
Percentile
(All Stocks)
Sales (5yr) 19.5% 14.8% 81%
Net Income (5yr) 68.3% 10.1% 97%
EPS (5yr) 42.5% 16.1% 90
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (21.7%) (15.4%) 30%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 8 8 8
Current EPS $0.158 $0.549 $0.653
Month Ago EPS $0.158 $0.555 $0.661
# Rev Up 1 1 1
# Rev Down 0 0 0
Three Months Ago EPS $0.157 $0.555 $0.664
Year/Year Chg 507.7% 77.1% 150.0%
Financials CLBT Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $514 $345 41%
Net Income (TTM) (Mil) $59 ($2) 56%
EPS (TTM) $0.237 ($0.100) 48%
Operating Cash Flow (TTM) (Mil) $158 $30 56%
Net Cash Flow (TTM) (Mil) ($5) $1 34%
Long-Term Debt (Q1) (Mil) $18 $34 32%
Enterprise Value (Q1) (Mil) na $1,096 na
Valuation CLBT Industry
Median
Percentile
(All Stocks)
P/B 5.14 3.41 78%
P/E 48.0 39.1 83%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 1.1 2.1 49%
Ratios CLBT Industry
Median
Percentile
(All Stocks)
Gross Margin 83.0% 69.8% 90%
Net Margin 11.4% 0.5% 66%
ROA 7.6% (1.2%) 81%
ROE 23.6% 1.2% 83%
Liabilities to Assets 45.9% 47.5% 37%
F-Score 4 5 33%

Cellebrite DI Ltd. did not pass any screens on 8/21/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors